Latest Shareholder Approvals News

Pure Resources Limited has bolstered its financial position with a $1.7 million placement and confirmed the presence of premium large to jumbo flake graphite at its Garnet Hills Project, setting the stage for downstream development in the US market.

Robex Resources has achieved a significant milestone with the first gold pour at its Kiniero Gold Project in Guinea, while securing strong shareholder backing for its merger with Predictive Discovery Limited.

M3 Mining Limited has identified promising new drill targets at its Edjudina Gold Project and secured additional funding to advance exploration activities, positioning the company for potential growth in Western Australia’s gold sector.

Forrestania Resources Limited has made significant strides in its expansion strategy during Q2 2025/2026, marked by the acquisition of Kula Gold Ltd, a substantial capital raise, and multiple project acquisitions across Western Australia.

Argent BioPharma has restructured its acquisition of AusCann assets to sharpen its clinical focus and secured a substantial A$11 million financing facility, positioning itself for growth in 2026.

Miramar Resources has secured an additional $1.1 million in investor commitments for its Tranche 2 placement, signalling sustained market confidence ahead of a shareholder vote in March 2026.

MCS Services Limited reported steady operations and positive cash flow for the December 2025 quarter while progressing the sale of its Highways Traffic subsidiary to Altus Traffic, pending shareholder approval.

ENRG Elements Limited has secured $2 million through a capital raise, renewed key uranium exploration permits in Niger, and is strategically pivoting towards gold opportunities in Central Asia, alongside a corporate rebranding to Barys Resources Limited.

Stelar Metals is actively expanding its project portfolio in Tier 1 jurisdictions while reassessing past assay results to capitalise on recent commodity price gains. The company also navigates leadership changes and Native Title negotiations as it prepares for a pivotal March update.

InhaleRx Limited has progressed its clinical trials for three drug candidates targeting cancer pain, panic disorder, and treatment-resistant depression, while securing additional funding and preparing for a company rebrand.

MinRex Resources has obtained a crucial ASX waiver allowing it to issue shares to Electrum Discovery shareholders without needing further shareholder approval, smoothing the path for its planned acquisition.

Assetora Limited has strengthened its financial footing by securing over $4 million in capital commitments and resolving all legacy administration matters, positioning itself for a potential ASX reinstatement.